0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global G-CSF Injection Market Research Report 2025
Published Date: 2025-06-04
|
Report Code: QYRE-Auto-5F16320
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global G CSF Injection Market Research Report 2023
BUY CHAPTERS

Global G-CSF Injection Market Research Report 2025

Code: QYRE-Auto-5F16320
Report
2025-06-04
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

G-CSF Injection Market

The global market for G-CSF Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for G-CSF Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for G-CSF Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of G-CSF Injection include Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for G-CSF Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G-CSF Injection.
The G-CSF Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global G-CSF Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the G-CSF Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of G-CSF Injection Market Report

Report Metric Details
Report Name G-CSF Injection Market
Segment by Type
  • Long-acting G-CSF Injection
  • Short-acting G-CSF Injection
Segment by Application
  • Neoplastic Diseases
  • Blood Disorders
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Shan Dong Kexing Biopharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of G-CSF Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of G-CSF Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the G-CSF Injection Market report?

Ans: The main players in the G-CSF Injection Market are Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Shan Dong Kexing Biopharm

What are the Application segmentation covered in the G-CSF Injection Market report?

Ans: The Applications covered in the G-CSF Injection Market report are Neoplastic Diseases, Blood Disorders, Others

What are the Type segmentation covered in the G-CSF Injection Market report?

Ans: The Types covered in the G-CSF Injection Market report are Long-acting G-CSF Injection, Short-acting G-CSF Injection

1 G-CSF Injection Market Overview
1.1 Product Definition
1.2 G-CSF Injection by Type
1.2.1 Global G-CSF Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Long-acting G-CSF Injection
1.2.3 Short-acting G-CSF Injection
1.3 G-CSF Injection by Application
1.3.1 Global G-CSF Injection Market Value by Application (2024 VS 2031)
1.3.2 Neoplastic Diseases
1.3.3 Blood Disorders
1.3.4 Others
1.4 Global G-CSF Injection Market Size Estimates and Forecasts
1.4.1 Global G-CSF Injection Revenue 2020-2031
1.4.2 Global G-CSF Injection Sales 2020-2031
1.4.3 Global G-CSF Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 G-CSF Injection Market Competition by Manufacturers
2.1 Global G-CSF Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global G-CSF Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global G-CSF Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of G-CSF Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of G-CSF Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of G-CSF Injection, Product Type & Application
2.7 Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
2.8 Global G-CSF Injection Market Competitive Situation and Trends
2.8.1 Global G-CSF Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest G-CSF Injection Players Market Share by Revenue
2.8.3 Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global G-CSF Injection Market Scenario by Region
3.1 Global G-CSF Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global G-CSF Injection Sales by Region: 2020-2031
3.2.1 Global G-CSF Injection Sales by Region: 2020-2025
3.2.2 Global G-CSF Injection Sales by Region: 2026-2031
3.3 Global G-CSF Injection Revenue by Region: 2020-2031
3.3.1 Global G-CSF Injection Revenue by Region: 2020-2025
3.3.2 Global G-CSF Injection Revenue by Region: 2026-2031
3.4 North America G-CSF Injection Market Facts & Figures by Country
3.4.1 North America G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America G-CSF Injection Sales by Country (2020-2031)
3.4.3 North America G-CSF Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe G-CSF Injection Market Facts & Figures by Country
3.5.1 Europe G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe G-CSF Injection Sales by Country (2020-2031)
3.5.3 Europe G-CSF Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific G-CSF Injection Market Facts & Figures by Region
3.6.1 Asia Pacific G-CSF Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific G-CSF Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific G-CSF Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America G-CSF Injection Market Facts & Figures by Country
3.7.1 Latin America G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America G-CSF Injection Sales by Country (2020-2031)
3.7.3 Latin America G-CSF Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa G-CSF Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa G-CSF Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa G-CSF Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global G-CSF Injection Sales by Type (2020-2031)
4.1.1 Global G-CSF Injection Sales by Type (2020-2025)
4.1.2 Global G-CSF Injection Sales by Type (2026-2031)
4.1.3 Global G-CSF Injection Sales Market Share by Type (2020-2031)
4.2 Global G-CSF Injection Revenue by Type (2020-2031)
4.2.1 Global G-CSF Injection Revenue by Type (2020-2025)
4.2.2 Global G-CSF Injection Revenue by Type (2026-2031)
4.2.3 Global G-CSF Injection Revenue Market Share by Type (2020-2031)
4.3 Global G-CSF Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global G-CSF Injection Sales by Application (2020-2031)
5.1.1 Global G-CSF Injection Sales by Application (2020-2025)
5.1.2 Global G-CSF Injection Sales by Application (2026-2031)
5.1.3 Global G-CSF Injection Sales Market Share by Application (2020-2031)
5.2 Global G-CSF Injection Revenue by Application (2020-2031)
5.2.1 Global G-CSF Injection Revenue by Application (2020-2025)
5.2.2 Global G-CSF Injection Revenue by Application (2026-2031)
5.2.3 Global G-CSF Injection Revenue Market Share by Application (2020-2031)
5.3 Global G-CSF Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen Inc.
6.1.1 Amgen Inc. Company Information
6.1.2 Amgen Inc. Description and Business Overview
6.1.3 Amgen Inc. G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Inc. G-CSF Injection Product Portfolio
6.1.5 Amgen Inc. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer G-CSF Injection Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sandoz (Novartis)
6.3.1 Sandoz (Novartis) Company Information
6.3.2 Sandoz (Novartis) Description and Business Overview
6.3.3 Sandoz (Novartis) G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sandoz (Novartis) G-CSF Injection Product Portfolio
6.3.5 Sandoz (Novartis) Recent Developments/Updates
6.4 Spectrum Pharmaceuticals
6.4.1 Spectrum Pharmaceuticals Company Information
6.4.2 Spectrum Pharmaceuticals Description and Business Overview
6.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Spectrum Pharmaceuticals G-CSF Injection Product Portfolio
6.4.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.5 Biocon Biologics Inc.
6.5.1 Biocon Biologics Inc. Company Information
6.5.2 Biocon Biologics Inc. Description and Business Overview
6.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biocon Biologics Inc. G-CSF Injection Product Portfolio
6.5.5 Biocon Biologics Inc. Recent Developments/Updates
6.6 Coherus BioSciences, Inc.
6.6.1 Coherus BioSciences, Inc. Company Information
6.6.2 Coherus BioSciences, Inc. Description and Business Overview
6.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Coherus BioSciences, Inc. G-CSF Injection Product Portfolio
6.6.5 Coherus BioSciences, Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical
6.7.1 Teva Pharmaceutical Company Information
6.7.2 Teva Pharmaceutical Description and Business Overview
6.7.3 Teva Pharmaceutical G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical G-CSF Injection Product Portfolio
6.7.5 Teva Pharmaceutical Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi G-CSF Injection Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Yifan Pharmaceutical
6.9.1 Yifan Pharmaceutical Company Information
6.9.2 Yifan Pharmaceutical Description and Business Overview
6.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yifan Pharmaceutical G-CSF Injection Product Portfolio
6.9.5 Yifan Pharmaceutical Recent Developments/Updates
6.10 CSPC
6.10.1 CSPC Company Information
6.10.2 CSPC Description and Business Overview
6.10.3 CSPC G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CSPC G-CSF Injection Product Portfolio
6.10.5 CSPC Recent Developments/Updates
6.11 Jiangsu Hengrui Medicine
6.11.1 Jiangsu Hengrui Medicine Company Information
6.11.2 Jiangsu Hengrui Medicine Description and Business Overview
6.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Hengrui Medicine G-CSF Injection Product Portfolio
6.11.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Company Information
6.12.2 Qilu Pharmaceutical Description and Business Overview
6.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Qilu Pharmaceutical G-CSF Injection Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 Shan Dong Kexing Biopharm
6.13.1 Shan Dong Kexing Biopharm Company Information
6.13.2 Shan Dong Kexing Biopharm Description and Business Overview
6.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shan Dong Kexing Biopharm G-CSF Injection Product Portfolio
6.13.5 Shan Dong Kexing Biopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 G-CSF Injection Industry Chain Analysis
7.2 G-CSF Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 G-CSF Injection Production Mode & Process Analysis
7.4 G-CSF Injection Sales and Marketing
7.4.1 G-CSF Injection Sales Channels
7.4.2 G-CSF Injection Distributors
7.5 G-CSF Injection Customer Analysis
8 G-CSF Injection Market Dynamics
8.1 G-CSF Injection Industry Trends
8.2 G-CSF Injection Market Drivers
8.3 G-CSF Injection Market Challenges
8.4 G-CSF Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global G-CSF Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global G-CSF Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global G-CSF Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global G-CSF Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global G-CSF Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global G-CSF Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global G-CSF Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market G-CSF Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of G-CSF Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of G-CSF Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of G-CSF Injection, Product Type & Application
 Table 12. Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global G-CSF Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global G-CSF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global G-CSF Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global G-CSF Injection Sales Market Share by Region (2020-2025)
 Table 19. Global G-CSF Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global G-CSF Injection Sales Market Share by Region (2026-2031)
 Table 21. Global G-CSF Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global G-CSF Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global G-CSF Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global G-CSF Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America G-CSF Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America G-CSF Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe G-CSF Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe G-CSF Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific G-CSF Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific G-CSF Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific G-CSF Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific G-CSF Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific G-CSF Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America G-CSF Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America G-CSF Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa G-CSF Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa G-CSF Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global G-CSF Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global G-CSF Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global G-CSF Injection Sales Market Share by Type (2020-2025)
 Table 53. Global G-CSF Injection Sales Market Share by Type (2026-2031)
 Table 54. Global G-CSF Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global G-CSF Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global G-CSF Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global G-CSF Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global G-CSF Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global G-CSF Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global G-CSF Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global G-CSF Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global G-CSF Injection Sales Market Share by Application (2020-2025)
 Table 63. Global G-CSF Injection Sales Market Share by Application (2026-2031)
 Table 64. Global G-CSF Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global G-CSF Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global G-CSF Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global G-CSF Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global G-CSF Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global G-CSF Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen Inc. Company Information
 Table 71. Amgen Inc. Description and Business Overview
 Table 72. Amgen Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Inc. G-CSF Injection Product
 Table 74. Amgen Inc. Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer G-CSF Injection Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Sandoz (Novartis) Company Information
 Table 81. Sandoz (Novartis) Description and Business Overview
 Table 82. Sandoz (Novartis) G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sandoz (Novartis) G-CSF Injection Product
 Table 84. Sandoz (Novartis) Recent Developments/Updates
 Table 85. Spectrum Pharmaceuticals Company Information
 Table 86. Spectrum Pharmaceuticals Description and Business Overview
 Table 87. Spectrum Pharmaceuticals G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Spectrum Pharmaceuticals G-CSF Injection Product
 Table 89. Spectrum Pharmaceuticals Recent Developments/Updates
 Table 90. Biocon Biologics Inc. Company Information
 Table 91. Biocon Biologics Inc. Description and Business Overview
 Table 92. Biocon Biologics Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Biocon Biologics Inc. G-CSF Injection Product
 Table 94. Biocon Biologics Inc. Recent Developments/Updates
 Table 95. Coherus BioSciences, Inc. Company Information
 Table 96. Coherus BioSciences, Inc. Description and Business Overview
 Table 97. Coherus BioSciences, Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Coherus BioSciences, Inc. G-CSF Injection Product
 Table 99. Coherus BioSciences, Inc. Recent Developments/Updates
 Table 100. Teva Pharmaceutical Company Information
 Table 101. Teva Pharmaceutical Description and Business Overview
 Table 102. Teva Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical G-CSF Injection Product
 Table 104. Teva Pharmaceutical Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sanofi G-CSF Injection Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Yifan Pharmaceutical Company Information
 Table 111. Yifan Pharmaceutical Description and Business Overview
 Table 112. Yifan Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Yifan Pharmaceutical G-CSF Injection Product
 Table 114. Yifan Pharmaceutical Recent Developments/Updates
 Table 115. CSPC Company Information
 Table 116. CSPC Description and Business Overview
 Table 117. CSPC G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. CSPC G-CSF Injection Product
 Table 119. CSPC Recent Developments/Updates
 Table 120. Jiangsu Hengrui Medicine Company Information
 Table 121. Jiangsu Hengrui Medicine Description and Business Overview
 Table 122. Jiangsu Hengrui Medicine G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jiangsu Hengrui Medicine G-CSF Injection Product
 Table 124. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 125. Qilu Pharmaceutical Company Information
 Table 126. Qilu Pharmaceutical Description and Business Overview
 Table 127. Qilu Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Qilu Pharmaceutical G-CSF Injection Product
 Table 129. Qilu Pharmaceutical Recent Developments/Updates
 Table 130. Shan Dong Kexing Biopharm Company Information
 Table 131. Shan Dong Kexing Biopharm Description and Business Overview
 Table 132. Shan Dong Kexing Biopharm G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shan Dong Kexing Biopharm G-CSF Injection Product
 Table 134. Shan Dong Kexing Biopharm Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. G-CSF Injection Distributors List
 Table 138. G-CSF Injection Customers List
 Table 139. G-CSF Injection Market Trends
 Table 140. G-CSF Injection Market Drivers
 Table 141. G-CSF Injection Market Challenges
 Table 142. G-CSF Injection Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of G-CSF Injection
 Figure 2. Global G-CSF Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global G-CSF Injection Market Share by Type: 2024 & 2031
 Figure 4. Long-acting G-CSF Injection Product Picture
 Figure 5. Short-acting G-CSF Injection Product Picture
 Figure 6. Global G-CSF Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global G-CSF Injection Market Share by Application: 2024 & 2031
 Figure 8. Neoplastic Diseases
 Figure 9. Blood Disorders
 Figure 10. Others
 Figure 11. Global G-CSF Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global G-CSF Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global G-CSF Injection Sales (2020-2031) & (K Units)
 Figure 14. Global G-CSF Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. G-CSF Injection Report Years Considered
 Figure 16. G-CSF Injection Sales Share by Manufacturers in 2024
 Figure 17. Global G-CSF Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest G-CSF Injection Players: Market Share by Revenue in G-CSF Injection in 2024
 Figure 19. G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global G-CSF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America G-CSF Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America G-CSF Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe G-CSF Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe G-CSF Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific G-CSF Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific G-CSF Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America G-CSF Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America G-CSF Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa G-CSF Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa G-CSF Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of G-CSF Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of G-CSF Injection by Type (2020-2031)
 Figure 53. Global G-CSF Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of G-CSF Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of G-CSF Injection by Application (2020-2031)
 Figure 56. Global G-CSF Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. G-CSF Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS